HomeDMAC • NASDAQ
DiaMedica Therapeutics Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 8.14M | 41.86% |
Net income | -7.71M | -49.62% |
Net profit margin | — | — |
Earnings per share | -0.18 | -28.57% |
EBITDA | -8.13M | -41.86% |
Effective tax rate | -0.08% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 36.52M | -21.49% |
Total assets | 38.83M | -21.17% |
Total liabilities | 4.88M | 67.50% |
Total equity | 33.95M | — |
Shares outstanding | 42.88M | — |
Price to book | 5.15 | — |
Return on assets | -47.81% | — |
Return on capital | -54.06% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -7.71M | -49.62% |
Cash from operations | -7.15M | -7.46% |
Cash from investing | 6.62M | 57.37% |
Cash from financing | 91.00K | 9,200.00% |
Net change in cash | -436.00K | 82.17% |
Free cash flow | -6.26M | -80.78% |
Previous close
$4.07
Day range
$3.82 - $4.28
Year range
$2.16 - $6.82
Market cap
180.11M USD
Avg Volume
91.75K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2000
Headquarters
Website
Employees
28
